99mTc-labeled-1-thio-β-d-glucose as a new tool to temporomandibular joint inflammatory disorders diagnosis-Reference-Cited by-同舟云学术

99mTc-labeled-1-thio-β-d-glucose as a new tool to temporomandibular joint inflammatory disorders diagnosis

Published:2010-12 Issue:12 Volume:68 Page:2261-2267
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Brasileiro Cláudia Borges,da Fonseca Pacheco Cinthia Mara,Queiroz-Junior Celso Martins,de Lima Carla Flávia,da Silva Juliana Batista,de Campos Tarcísio Passos Ribeiro

Publisher

Elsevier BV

Subject

Radiation

Reference57 articles.

1. Temporomandibular joint arthroscopic findings in patients with cervical flexion–extension injury (Whiplash): a preliminary study of 30 patients;Abd-Ul-Salam;J. Can. Dent. Assoc.,2002

2. The role of nuclear medicine in infection and inflammation;Becker;Lancet Infect. Dis.,2001

3. Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET;Beckers;J. Nucl. Med.,2004

4. Technetium-99m labelled liposomes to image experimental arthritis;Boerman;Ann. Rheum. Dis.,1997

5. Efeito da dexametasona e do meloxicam sobre o extravasamento plasmático induzido por carragenina na ATM de ratos;Boleta-Ceranto;Rev. Odonto Cienc.,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 99m Tc Radiopharmaceutical Chemistry;Handbook of Radiopharmaceuticals;2020-12-21

2. Nuclear Imaging of Glucose Metabolism: Beyond 18F-FDG;Contrast Media & Molecular Imaging;2019-03-26

3. Novel 99mTc-Labeled Glucose Derivative for Single Photon Emission Computed Tomography: A Promising Tumor Imaging Agent;Molecular Pharmaceutics;2018-07-09

4. The role of regulatory T cells, interleukin-10 and in vivo scintigraphy in autoimmune and idiopathic diseases – Therapeutic perspectives and prognosis;Revista da Associação Médica Brasileira;2017-12

5. Preparation and Primary Bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as Melanoma Targeting Agent;Current Radiopharmaceuticalse;2011-10-01